Developing new vaccines to protect against influenza viruses
Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component A: Vaccine Center
This study is all about developing new flu vaccines that could offer better and longer-lasting protection against different types of the flu virus, and it invites patients to help test how well these vaccines work in real life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11042033 on NIH RePORTER |
What this research studies
This research focuses on creating and testing innovative influenza vaccine candidates that aim to provide long-lasting and broad protection against various strains of the influenza virus. The approach includes conducting immunologic analyses to guide vaccine design, as well as performing laboratory tests to evaluate the vaccine's effectiveness and safety. Patients may be involved in clinical trials to assess how well these new vaccines work in real-world settings, contributing to the advancement of public health.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals at high risk for influenza complications, such as the elderly, young children, and those with underlying health conditions.
Not a fit: Patients who are not at risk for influenza or those who have already received effective vaccination may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and longer-lasting influenza vaccines, improving protection for patients against seasonal and pandemic influenza.
How similar studies have performed: Other research has shown promise in developing innovative vaccine strategies, indicating that this approach has the potential for success.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Moody, Tony — Duke University
- Study coordinator: Moody, Tony
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.